Showing 146,001 - 146,020 results of 227,700 for search '(( 5 ((wt decrease) OR (we decrease)) ) OR ( 10 ((nn decrease) OR (a decrease)) ))', query time: 2.36s Refine Results
  1. 146001

    Nuclear arms races: Experimental evolution for mating success in the mushroom-forming fungus <i>Schizophyllum commune</i> by Bart P. S. Nieuwenhuis (6160661)

    Published 2018
    “…Even though only two of those five remained significant after correcting for multiple comparisons, for all five lines we found a correlation between the efficiency with which the female mycelium is accessed and fitness, providing additional circumstantial evidence for fitness change in those five lines. …”
  2. 146002

    Free energy properties in cultured neural networks. by Takuya Isomura (839119)

    Published 2015
    “…After training, the expectation of internal energy decreased (*, <i>p</i> = 0.023; <i>n</i> = 23 cultures), Shannon entropy significantly increased (****, <i>p</i> < 10<sup>−4</sup>; <i>n</i> = 23 cultures), and free energy significantly decreased (****, <i>p</i> < 10<sup>−4</sup>; <i>n</i> = 23 cultures). …”
  3. 146003

    Image_4_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  4. 146004

    Image_6_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  5. 146005

    Image_1_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  6. 146006

    Image_2_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  7. 146007

    Image_3_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg by Mona M. Al-Gizawiy (17787488)

    Published 2024
    “…</p>Results<p>In this study we demonstrate non-invasively, using longitudinal MRI surveillance, the potent antineoplastic effects of GaM in a novel rat xenograft model of trGBM, as evidenced by extended suppression of tumor growth (23.56 mm<sup>3</sup>/week untreated, 5.76 mm<sup>3</sup>/week treated, P < 0.001), a blunting of tumor perfusion, and a significant survival benefit (median overall survival: 30 days untreated, 56 days treated; P < 0.001). …”
  8. 146008

    Data_Sheet_1_Linking Multiscalar Fisheries Using Metacoupling Models.pdf by Andrew K. Carlson (8558910)

    Published 2020
    “…However, research approaches that consider human–nature interactions within as well as between adjacent and distant fisheries are scarce. As such, we measured and modeled marine fisheries catches at local and regional scales over 65 years (1950–2014), assessed cross-scalar interactions among fishing types (artisanal, subsistence, industrial, recreational), and predicted future catches using the metacoupling framework, a new approach for evaluating human-nature interactions within and across adjacent and distant fisheries (metacouplings). …”
  9. 146009

    Image_1_Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma.pdf by Gang Guo (146383)

    Published 2021
    “…The objective response was assessed 3 months later, five partial response, two stable disease (SD), the mean greatest tumor diameter of all patients decreased from 9.6 to 5.2cm. …”
  10. 146010

    Supplementary Material for: Interdigitation and Ellipsoid Zones Disruption Correlate with Visual Outcomes among Treatment-Naive Patients with Diabetic Macular Edema by Sharef N. (10349900)

    Published 2021
    “…<b><i>Introduction:</i></b> We have recently shown that defects in interdigitation and ellipsoid zones (IZ and EZ) can predict response to anti-VEGF therapy in a small group of treatment-naive diabetic macular edema (DME) patients. …”
  11. 146011
  12. 146012
  13. 146013
  14. 146014
  15. 146015
  16. 146016
  17. 146017
  18. 146018
  19. 146019
  20. 146020